Principal Investigator
Dr. Gautam Singhvi
Funding Agency
Slyback Pharma
Type of Project
Industry
Sanction Amount (INR)
14
End Date
29/03/2022
Status
Completed
This website uses cookies or similar technologies, to enhance your browsing experience.